MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER

A combined medicament that comprises particles containing an amphiphilic polymer, in which the hydrophobic segment is a poly(hydroxy acid) and the hydrophilic segment is a polysaccharide, and a cancer antigen with an immune-activating factor. By using the combined medicament in such a manner that th...

Full description

Saved in:
Bibliographic Details
Main Authors OKANO Fumiyoshi, SHIBAHARA Kyoko
Format Patent
LanguageEnglish
French
Japanese
Published 23.03.2023
Subjects
Online AccessGet full text

Cover

More Information
Summary:A combined medicament that comprises particles containing an amphiphilic polymer, in which the hydrophobic segment is a poly(hydroxy acid) and the hydrophilic segment is a polysaccharide, and a cancer antigen with an immune-activating factor. By using the combined medicament in such a manner that the particles and the immune-activating factor are administered separately to a subject, the effectiveness of cancer treatment and/or prevention can be enhanced. Un médicament combiné qui comprend des particules contenant un polymère amphiphile, dans lequel le segment hydrophobe est un poly(hydroxyacide) et le segment hydrophile est un polysaccharide, et un antigène du cancer avec un facteur d'activation immunitaire. L'utilisation du médicament combiné de telle sorte que les particules et le facteur d'activation immunitaire sont administrés séparément à un sujet permet d'améliorer l'efficacité du traitement et/ou de la prévention du cancer. 疎水性セグメントがポリ(ヒドロキシ酸)であり、親水性セグメントが多糖である両親媒性ポリマー及び癌抗原を含む粒子、並びに免疫活性化因子を含む組合せ医薬品を、前記粒子及び免疫活性化因子が被験者に別々に投与されるように用いることによって、癌の治療及び/又は予防効果を高めることができる。
Bibliography:Application Number: WO2022JP34501